NXTC – Nextcure Inc
NXTC
$2.33Name : NextCure, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $8,416,183.00
EPSttm : -16.82
NextCure, Inc.
$2.33
NXTC — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
2.4
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.24
EPS Last/This Y
12.72
EPS This/Next Y
-1.42
Price
2.3
Target Price
19.33
Analyst Recom
1
Performance Q
-81.67
Upside
-10,739.9%
Beta
1.43
Ticker: NXTC
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | NXTC | 9.74 | N/A | N/A | 0 |
| 2026-05-12 | NXTC | 9.9 | N/A | N/A | 0 |
| 2026-05-13 | NXTC | 9.86 | N/A | N/A | 0 |
| 2026-05-14 | NXTC | 10.11 | N/A | N/A | 0 |
| 2026-05-15 | NXTC | 9.83 | N/A | N/A | 0 |
| 2026-05-18 | NXTC | 9.32 | N/A | N/A | 0 |
| 2026-05-19 | NXTC | 9.13 | N/A | N/A | 0 |
| 2026-05-20 | NXTC | 9.81 | N/A | N/A | 0 |
| 2026-05-21 | NXTC | 10.13 | N/A | N/A | 0 |
| 2026-05-22 | NXTC | 7.84 | N/A | N/A | 0 |
| 2026-05-26 | NXTC | 6.97 | N/A | N/A | 0 |
| 2026-05-27 | NXTC | 6.07 | N/A | N/A | 0 |
| 2026-05-28 | NXTC | 6.38 | N/A | N/A | 0 |
| 2026-05-29 | NXTC | 6.18 | N/A | N/A | 0 |
| 2026-06-02 | NXTC | 3.36 | N/A | N/A | 0 |
| 2026-06-03 | NXTC | 3.23 | N/A | N/A | 0 |
| 2026-06-04 | NXTC | 3.21 | N/A | N/A | 0 |
| 2026-06-05 | NXTC | 2.91 | N/A | N/A | 0 |
| 2026-06-08 | NXTC | 2.76 | N/A | N/A | 0 |
| 2026-06-09 | NXTC | 2.32 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | NXTC | 9.86 | 61.3 | 59.2 | -8.98 |
| 2026-05-12 | NXTC | 9.62 | 56.6 | - | -8.98 |
| 2026-05-13 | NXTC | 9.90 | 56.6 | - | -8.98 |
| 2026-05-14 | NXTC | 10.48 | 56.6 | - | -8.98 |
| 2026-05-15 | NXTC | 9.51 | 56.6 | - | -7.69 |
| 2026-05-18 | NXTC | 9.41 | 83.7 | - | -7.69 |
| 2026-05-19 | NXTC | 9.17 | 83.7 | - | -7.69 |
| 2026-05-20 | NXTC | 9.43 | 83.5 | - | -6.93 |
| 2026-05-21 | NXTC | 10.60 | 83.5 | - | -6.93 |
| 2026-05-22 | NXTC | 7.84 | 83.5 | - | -6.93 |
| 2026-05-26 | NXTC | 7.02 | 83.5 | - | -6.93 |
| 2026-05-27 | NXTC | 6.03 | 83.5 | - | -6.93 |
| 2026-05-28 | NXTC | 6.34 | 83.5 | - | -6.93 |
| 2026-05-29 | NXTC | 6.26 | 83.5 | - | -6.93 |
| 2026-06-01 | NXTC | 3.38 | 83.5 | - | -6.93 |
| 2026-06-02 | NXTC | 3.37 | 83.5 | - | -6.93 |
| 2026-06-03 | NXTC | 3.16 | 83.5 | - | -6.93 |
| 2026-06-04 | NXTC | 3.19 | 83.5 | - | -6.93 |
| 2026-06-05 | NXTC | 2.91 | 83.5 | - | -6.93 |
| 2026-06-08 | NXTC | 2.75 | 83.5 | - | -6.93 |
| 2026-06-09 | NXTC | 2.30 | 83.5 | - | -6.93 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | NXTC | 0.00 | 17.30 | 2.99 |
| 2026-05-12 | NXTC | 0.00 | 17.30 | 2.99 |
| 2026-05-13 | NXTC | 0.00 | 17.30 | 2.99 |
| 2026-05-14 | NXTC | 0.00 | 17.30 | 2.99 |
| 2026-05-15 | NXTC | 0.00 | 17.30 | 2.99 |
| 2026-05-18 | NXTC | 0.00 | 17.16 | 2.98 |
| 2026-05-19 | NXTC | 0.00 | 17.16 | 2.98 |
| 2026-05-20 | NXTC | 0.00 | 17.16 | 2.98 |
| 2026-05-21 | NXTC | 0.00 | 17.16 | 2.98 |
| 2026-05-22 | NXTC | 0.00 | 17.16 | 2.98 |
| 2026-05-26 | NXTC | 0.00 | 7.71 | 2.98 |
| 2026-05-27 | NXTC | 0.00 | 7.71 | 2.98 |
| 2026-05-28 | NXTC | 0.00 | 7.71 | 2.40 |
| 2026-05-29 | NXTC | 0.00 | 7.71 | 2.40 |
| 2026-06-02 | NXTC | 0.00 | 7.39 | 2.40 |
| 2026-06-03 | NXTC | 0.00 | 7.39 | 2.40 |
| 2026-06-04 | NXTC | 0.00 | 7.39 | 2.40 |
| 2026-06-05 | NXTC | 0.00 | 7.39 | 2.40 |
| 2026-06-08 | NXTC | 0.00 | 7.39 | 2.40 |
| 2026-06-09 | NXTC | 0.00 | 7.39 | 2.40 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-1.87
Avg. EPS Est. Current Quarter
-1.86
Avg. EPS Est. Next Quarter
-1.63
Insider Transactions
Institutional Transactions
7.39
Beta
1.43
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
18
Sentiment Score
24
Actual DrawDown %
97.9
Max Drawdown 5-Year %
-97.5
Target Price
19.33
P/E
Forward P/E
PEG
P/S
P/B
0.31
P/Free Cash Flow
EPS
-19.07
Average EPS Est. Cur. Y
-6.93
EPS Next Y. (Est.)
-8.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.87
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
1.28
EBIT Estimation
◆
NXTC
Healthcare
$2.33
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
5/25
Volume
3/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
20.4
Range 1M
0%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
16/25
Growth
16/30
Estimates
0/20
Inst/Vol
8/15
Options
0/10
EPS Yr
62.7%
EPS NY
-13.9%
52W%
0%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+729.6% upside
Quality
2/30
Valuation
16/30
Growth
9/25
Stability
7/10
LT Trend
4/5
Upside
+729.6%
Quality
3
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 40
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland.
NXTC
Latest News
—
Caricamento notizie per NXTC…
stock quote shares NXTC – Nextcure Inc Stock Price stock today
news today NXTC – Nextcure Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch NXTC – Nextcure Inc yahoo finance google finance
stock history NXTC – Nextcure Inc invest stock market
stock prices NXTC premarket after hours
ticker NXTC fair value insiders trading